EGFR and non-small cell lung carcinoma: To date, several investigations have demonstrated EGFR gene mutations detected in cfDNA are highly concordant with those detected in tumor tissue of NSCLC patients, although with a variance (74–97%) mainly linked to the gene-test [35,36,37,38,39].